Streetbeat News

Products Services

CAMT

Camtek Ltd. (NASDAQ: CAMT) shares are trading higher after the company received orders for 42 systems from several tier-1 semiconductor manufacturers. The systems, mainly for the manufacturing of chiplet modules and High Bandwidth Memory (HBM), are expected to be delivered in the second half of 2023. The company anticipates further orders due to growing demand for increased computing power supporting AI and data centers.

Portfolio Pulse from Akanksha Bakshi

July 13, 2023 | 1:04 pm

AMZN

Amazon.com reported that during a 2-day event, Prime members purchased over 375 million items worldwide, saving more than $2.5 billion on millions of deals.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 1:03 pm

CLIR

ClearSign Technologies Corporation's partner, Narion, has been awarded a $250,000 phase one SBIR grant from the Department of Energy to develop a technology utilizing ClearSign's sensor. This technology will enable the efficient and complete combustion of flared waste gas, reducing greenhouse gas emissions and the carbon emissions of flaring systems.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:01 pm

EGHT

8x8, Inc. has launched the 8x8 Technology Partner Ecosystem, a new initiative aimed at enhancing customer experience and business outcomes. The program will bring together best-of-breed solutions and will provide customers with a range of integrated cloud communications and contact center solutions.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 1:01 pm

PRGO

Perrigo Company plc (PRGO) announced that it has received FDA approval for Opill, an over-the-counter daily oral contraceptive. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 1:01 pm

VRPX

Virpax Pharmaceuticals has filed a new provisional patent application for its product candidate Envelta, which uses Molecular Envelope Technology (MET) for intranasal delivery of Enkephalin for severe cancer and non-cancer pain. The MET was developed by Nanomerics Ltd., which has licensed its technology to Virpax. The development program for Envelta is being funded almost exclusively through a Cooperative Research and Development Agreement with the National Center for Advancing Translational Sciences.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:59 pm

DGX

Quest Diagnostics (NYSE:DGX) has launched a novel prostate cancer biomarker test in collaboration with Envision Sciences. The test, developed through Quest's subspecialty pathology business AmeriPath, aims to improve the diagnosis and grading of prostate cancer. The test uses Envision's proprietary biomarker and immunohistochemistry technology, which has shown to upgrade 22% of tissue specimens and downgrade 20% compared to conventional assessment methods. The test is available for order by physicians in the United States, excluding New York.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 12:46 pm

NVVE

Nuvve Holding Corp. (NASDAQ:NVVE) will supply NRT Bus, a Beacon Mobility subsidiary, with 25 bi-directional Nuvve DC Rapid HD Charging Stations for Lawrence Public Schools in Massachusetts. The chargers will power a fleet of 25 new electric school buses manufactured by Thomas Built Buses. The charger order was disclosed in Q2 2023, with the units expected to be delivered by December while the buses arrive later in 2024. The charging stations come preconfigured to work with Nuvve's GIVe™ platform for intelligently charging and discharging to the grid.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 12:45 pm

CHRS

Coherus BioSciences, Inc. (NASDAQ:CHRS) and Superior Biologics, Inc. have announced a national distribution agreement for YUSIMRY, a biosimilar of Humira, at a price of $995 per carton of two autoinjectors, representing a discount of more than 85% compared to Humira. This is the first formal distribution agreement for YUSIMRY and is expected to provide patients and employers with a low-cost, high-quality treatment option.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 12:44 pm

APDN

AULT

DFLI

Applied DNA (APDN) has acquired Spindle Biotech, launching the LineaIVT(TM) platform to improve mRNA manufacturing and broaden market reach. Dragonfly Energy (DFLI) is set to be granted a U.S. patent for a unique battery pack assembly design. Ault Alliance (AULT) announces a second partial distribution of TOG securities at approximately $0.37 per share of Ault Alliance common stock.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:44 pm